Search research articles
Contact Us
Filters
Showing results (951-960 of 1,095) with videos related to
Page
of 110
Sort By:
JHEP Reports : Innovation in Hepatology
|
July 24, 2023
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology
|
December 31, 2017
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C
Javier Ampuero, Carlota Jimeno, Rosa Quiles, et al.
Cancer Immunology, Immunotherapy : CII
|
June 4, 2024
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations
Lorena Incorvaia, Fernando Sabino Marques Monteiro, Francesco Massari, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 10, 2011
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Markus Cornberg, Homie A Razavi, Alfredo Alberti, et al.
Clinical & Experimental Metastasis
|
November 21, 2025
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study
Renate Pichler, Gerald Klinglmair, Kirstin Binz, et al.
Gastroenterology
|
September 28, 2023
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology
|
September 21, 2023
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
Ho Soo Chun, George V Papatheodoridis, Minjong Lee, et al.
JHEP Reports : Innovation in Hepatology
|
May 1, 2026
Clinical features and management for CDK4/6 inhibitor-DILI
Mar Riveiro-Barciela, Paula Esteban, Kreina Sharela Vega-Cano, et al.
Journal of Viral Hepatitis
|
January 5, 2023
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, et al.
Anti-Cancer Drugs
|
May 31, 2018
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma
Roberto Iacovelli, Maria Cossu Rocca, Luca Galli, et al.
Page
of 110
Search research articles
Search
Showing results (951-960 of 1,095) with videos related to
Sort By:
Page
of 110
JHEP Reports : Innovation in Hepatology
|
July 24, 2023
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort study
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology
|
December 31, 2017
Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C
Javier Ampuero, Carlota Jimeno, Rosa Quiles, et al.
Cancer Immunology, Immunotherapy : CII
|
June 4, 2024
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations
Lorena Incorvaia, Fernando Sabino Marques Monteiro, Francesco Massari, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 10, 2011
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
Markus Cornberg, Homie A Razavi, Alfredo Alberti, et al.
Clinical & Experimental Metastasis
|
November 21, 2025
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study
Renate Pichler, Gerald Klinglmair, Kirstin Binz, et al.
Gastroenterology
|
September 28, 2023
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy
Milan J Sonneveld, Shao-Ming Chiu, Jun Yong Park, et al.
Journal of Hepatology
|
September 21, 2023
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B
Ho Soo Chun, George V Papatheodoridis, Minjong Lee, et al.
JHEP Reports : Innovation in Hepatology
|
May 1, 2026
Clinical features and management for CDK4/6 inhibitor-DILI
Mar Riveiro-Barciela, Paula Esteban, Kreina Sharela Vega-Cano, et al.
Journal of Viral Hepatitis
|
January 5, 2023
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, et al.
Anti-Cancer Drugs
|
May 31, 2018
The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma
Roberto Iacovelli, Maria Cossu Rocca, Luca Galli, et al.
Page
of 110